Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvants: Classification,Modus Operandi, and Licensing
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Fernanda Caroline Coirada, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-16
Open Access | Times Cited: 260

Showing 1-25 of 260 citing articles:

Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 228
Manganese salts function as potent adjuvants
Rui Zhang, Chenguang Wang, Yukun Guan, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1222-1234
Open Access | Times Cited: 205
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Vivek P. Chavda, Lalitkumar K. Vora, Anjali Pandya, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2619-2636
Open Access | Times Cited: 193
Old and new adjuvants
Amy S. McKee, Philippa Marrack
Current Opinion in Immunology (2017) Vol. 47, pp. 44-51
Open Access | Times Cited: 179
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 168
Polysaccharide-based nanomedicines for cancer immunotherapy: A review
Yujun Zeng, Yufan Xiang, Ruilong Sheng, et al.
Bioactive Materials (2021) Vol. 6, Iss. 10, pp. 3358-3382
Open Access | Times Cited: 121
Current status and development prospects of aquatic vaccines
Du Yang, Xiaoman Hu, Miao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 75
Advances in Infectious Disease Vaccine Adjuvants
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1120-1120
Open Access | Times Cited: 74
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 49
Designer outer membrane vesicles as immunomodulatory systems – Reprogramming bacteria for vaccine delivery
Yehou M.D. Gnopo, Hannah C. Watkins, Taylor C. Stevenson, et al.
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 132-142
Closed Access | Times Cited: 153
Mucosal vaccines: Strategies and challenges
Miao Li, Yi Wang, Yuan Sun, et al.
Immunology Letters (2019) Vol. 217, pp. 116-125
Closed Access | Times Cited: 145
Vaccine adjuvants: smart components to boost the immune system
Rakesh Bastola, Gyubin Noh, Taekwang Keum, et al.
Archives of Pharmacal Research (2017) Vol. 40, Iss. 11, pp. 1238-1248
Closed Access | Times Cited: 140
Antibody Engineering for Pursuing a Healthier Future
Abdullah F. U. H. Saeed, Rongzhi Wang, Sumei Ling, et al.
Frontiers in Microbiology (2017) Vol. 8
Open Access | Times Cited: 139
Nanovaccine: A novel approach in immunization
Seyed Mohammad Gheibi Hayat, Majid Darroudi
Journal of Cellular Physiology (2019) Vol. 234, Iss. 8, pp. 12530-12536
Closed Access | Times Cited: 131
Selection of adjuvants for vaccines targeting specific pathogens
Indranil Sarkar, Ravendra Garg, Sylvia van Drunen Littel‐van den Hurk
Expert Review of Vaccines (2019) Vol. 18, Iss. 5, pp. 505-521
Open Access | Times Cited: 96
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo, Sara M. Mangsbo, Divya Nagarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 96
Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy
Lin Qin, Huilin Zhang, Yang Zhou, et al.
Small (2021) Vol. 17, Iss. 28
Closed Access | Times Cited: 87
Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
Cynthia Calzas, Christophe Chevalier
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 78
Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
Jia Zhuang, Maya Holay, Joon Ho Park, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7826-7848
Open Access | Times Cited: 78
Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants
Xinhuan Wan, Yiming Yin, Zhou Chang-zheng, et al.
Carbohydrate Polymers (2021) Vol. 276, pp. 118739-118739
Closed Access | Times Cited: 78
Developments in Vaccine Adjuvants
Farrhana Ziana Firdaus, Mariusz Skwarczyński, István Tóth
Methods in molecular biology (2021), pp. 145-178
Closed Access | Times Cited: 75
Use of Protamine in Nanopharmaceuticals—A Review
Ivana Ruseska, Katja Fresacher, Christina Petschacher, et al.
Nanomaterials (2021) Vol. 11, Iss. 6, pp. 1508-1508
Open Access | Times Cited: 60
The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development
Michael Kozak, Jiafen Hu
Vaccines (2023) Vol. 11, Iss. 3, pp. 695-695
Open Access | Times Cited: 29
Nasal sprays for treating COVID-19: a scientific note
Vivek P. Chavda, Kajal Baviskar, Dixa A. Vaghela, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 2, pp. 249-265
Open Access | Times Cited: 26
Subunit vaccines for Acinetobacter baumannii
Ning Yang, Xiao Jin, Chenghua Zhu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top